泽璟制药 (688266.SH)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

财务分析(报告期)(泽璟制药)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年一季报2023年年报2023年三季报2023年中报2023年一季报2022年年报2022年三季报2022年中报2022年一季报
主要指标:
 营业收入(元) 108,244,408.58386,438,784.02282,104,804.49219,928,154.33108,110,475.27302,305,057.49197,892,872.37105,400,037.3143,725,271.60
 营业利润(元) -45,624,274.29-297,782,398.33-216,367,630.78-122,160,868.74-60,366,786.42-485,557,494.31-388,331,361.13-263,512,327.72-127,167,812.22
 利润总额(元) -45,623,831.81-299,084,511.68-217,267,650.25-122,742,352.09-60,839,166.95-487,954,729.84-389,946,728.29-264,658,517.89-127,603,412.22
 净利润(元) -44,630,785.90-295,134,953.99-214,296,136.14-120,802,756.89-59,875,793.87-485,949,358.10-387,326,926.68-262,970,695.96-126,748,913.01
 归属于母公司股东的净利润(元) -39,499,383.01-278,582,744.17-202,089,409.77-114,228,726.64-57,227,635.33-457,771,812.39-363,745,077.96-247,008,758.20-119,438,902.55
盈利能力:
 销售毛利率(%) 93.4092.4492.4092.5093.0891.3591.5491.9992.26
 销售净利率(%) -41.23-76.37-75.96-54.93-55.38-160.75-195.73-249.50-289.88
 净资产收益率(%) -3.43-23.29-15.69-8.25-6.44----
 总资产报酬率ROA(%) -2.20-13.78-10.10-5.61-3.65----
 投入资本回报率ROIC(%) -1.56-14.84-10.58-6.01-4.41-34.74-27.70-18.99-8.87
营运能力:
 存货周转率(次) 0.060.280.220.180.09----
 应收账款周转率(次) 1.054.073.593.002.10----
 总资产周转率(次) 0.050.170.130.100.06----
偿债能力:
 资产负债率(%) 48.4443.0338.8135.8955.8952.8046.3439.1334.09
 股东权益比率(%) 51.3356.5560.5863.3142.5845.5051.6458.5163.27
 已获利息倍数(倍) 7.5521.1123.8738.40178.2636.7732.6429.0424.68
 流动比率 2.252.222.382.651.551.772.062.633.22
 速动比率 2.092.072.202.461.351.551.842.352.90
发展能力:
 营业收入增长率(%) 0.1227.8342.55108.66147.2558.81100.75148.53-
 营业利润增长率(%) 24.4238.6744.2853.6452.53-5.78-26.83-40.61-51.47
 税后利润增长率(%) 30.9839.0844.4453.7652.09-1.50-24.28-39.58-49.84
 净资产增长率(%) 124.78115.10105.4091.14-33.67-36.55-37.43-34.51-30.80
 总资产增长率(%) 86.4873.0675.0876.64-1.45-4.45-11.81-15.59-11.82

前瞻产业研究院